Skip to main content
. 2019 Jul 8;60(1):28–36. doi: 10.1002/jcph.1470

Table 4.

Summary of TEAEs and ADRs

ONO‐4474 Placebo
Adverse Event (n = 55) (n = 55)
Total TEAEs, n (%) 23 (41.8) 10 (18.2)
Serious TEAEs, n (%) 1 (1.8)
Discontinued treatment due to TEAEs, n (%) 4 (7.3) 1 (1.8)
Total ADRs, n (%) 16 (29.1) 7 (12.7)
Serious ADRs, n (%)
Discontinued treatment due to ADRs, n (%) 3 (5.5) 1 (1.8)

ADR, adverse drug reaction; TEAE, treatment‐emergent adverse event.